Abiopharma

JEFFERSON CAPITAL, INC. / DE (JCAP)

Symbol	JCAP
Name	JEFFERSON CAPITAL, INC. / DE
Sector	FINANCE
Region	North America
Industry	Short-Term Business Credit Institutions
Address	600 SOUTH HIGHWAY 169, SUITE 1575, MINNEAPOLIS, MN 55426
Telephone	(320) 229-8505
Fax	—
Email	—
Website	https://www.jcap.com/
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0002046042
Description	Jefferson Capital is a leading analytically driven purchaser and manager of charged-off and insolvency consumer accounts with operations primarily in the United States, Canada, the United Kingdom and Latin America. The accounts we purchase are primarily the unpaid obligations of individuals owed to credit grantors, which include banks, non-bank consumer lenders, auto finance companies, utilities and telecom companies. We purchase nonperforming consumer loans and receivables at a discount to their face value across a broad range of financial assets, including where the account holder has initiated a bankruptcy proceeding, or an equivalent proceeding in Canada or the United Kingdom. We manage the loans and receivables by working with the account holders as they repay their obligations and work toward financial recovery. Additional info from NASDAQ: Jefferson Capital is a leading analytically driven purchaser and manager of charged-off and insolvency consumer accounts with operations primarily in the United States, Canada, the United Kingdom and Latin America. The accounts we purchase are primarily the unpaid obligations of individuals owed to credit grantors, which include banks, non-bank consumer lenders, auto finance companies, utilities and telecom companies. We purchase nonperforming consumer loans and receivables at a discount to their face value across a broad range of financial assets, including where the account holder has initiated a bankruptcy proceeding, or an equivalent proceeding in Canada or the United Kingdom. We manage the loans and receivables by working with the account holders as they repay their obligations and work toward financial recovery.

2026-08-21 10:01

(35% Negative) JEFFERSON CAPITAL, INC. / DE (JCAP) Announces Business Combination

2026-08-18 20:01

(30% Negative) JEFFERSON CAPITAL, INC. / DE (JCAP) Announces Business Combination

2026-08-18 18:02

Jefferson Capital Announces Pricing of $100 Million of Senior Notes due 2030

2026-08-18 11:51

Jefferson Capital Announces Proposed Private Offering of Senior Notes

2026-08-17 19:13

📋 Zellmann Mark Joseph (Officer) plans to sell 56K shares of Jefferson Capital, Inc. / DE (at $23.75 each, total $1.3M) Filed: Aug 17, 2026 | ID: 006098

2026-08-13 17:06

New Form SCHEDULE 13G/A - Jefferson Capital, Inc. / DE Filed: 2026-08-13 AccNo: 0000902219-26-000234 Size: 15 KB

2026-07-30 20:05

Jefferson Capital to Announce Second Quarter 2026 Results

2026-07-20 07:02

New Form EFFECT - Jefferson Capital, Inc. / DE Filed: 2026-07-17 AccNo: 9999999995-26-002350 Size: 1 KB

2026-07-02 17:05

New Form S-3 - Jefferson Capital, Inc. / DE Filed: 2026-07-02 AccNo: 0001104659-26-080303 Size: 1 MB

2026-06-08 20:05

(99% Neutral) JEFFERSON CAPITAL, INC. / DE (JCAP) Announces Regulatory Update